Shay Capital »

Spero Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $528k 307k 1.72

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alibaba Group Hldg Sponsored Ads (BABA)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Datadog Cl A Com (DDOG)
Viking Therapeutics (VKTX)
Golar Lng SHS (GLNG)
Endeavor Group Hldgs Cl A Com (EDR)
Tillys Cl A (TLYS)
Baidu Spon Adr Rep A (BIDU)
Genworth Finl Com Cl A (GNW)
Snowflake Cl A (SNOW)
Mbia (MBI)
Turtle Beach Corp Com New (HEAR)
Advanced Micro Devices (AMD)

View all positions for Shay Capital

Top funds holding Spero Therapeutics

Frigate Ventures
Vanguard Group
ADAR1 Capital Management
Alphabet
Murchinson
Renaissance Technologies
Acadian Asset Management
Atlas Venture Life Science Advisors
BlackRock
Geode Capital Management
Novo A/S
AWM Investment Company
Shay Capital
Man Group
Bridgeway Capital Management

View all funds holding Spero Therapeutics